The challenge of creating sustainable healthcare systems is very important not only for Lithuania, but for the whole of the European Union. The theme also has a wider resonance for the whole world, believes Vytenis Povilas Andriukaitis, Minister of Health of the Republic of Lithuania.
A snapshot video of the multi-stakeholder dialogue on affordability and quality of medicines in developing countries hosted by the Access to Medicine Foundation in Accra, Ghana on 25-26 June, 2013. For a full report, please check our website.
This session is chaired by Adam Smith, Editorial Director, Nobel Media AB and features the following speakers:
IMI -- a view from the European Parliament provided by Françoise Grossetête, MEP, European Parliament, The biopharmaceutical industry and IMI by Richard Bergström, Director General, EFPIA and, The European Commission and IMI by Robert-Jan Smits, Director-General for Research and Innovation, European Commission.
The European Union (EU) has introduced a new process to label medicines that are being monitored particularly closely by regulatory authorities. These medicines are described as being under 'additional monitoring'.
A discussion with Gisela Payeras, Vice-Chair of EFPIA's External Trade Policy Committee (ETPC)
From the August 27 conference "A roadmap for sharing clinical trial data": EFPIA Director General Richard Bergström explains the EFPIA PhRMA data sharing agreement.